James Edgemond
CFO AND TREASURER · UNITED THERAPEUTICS Corp
- 2024
- Jun 23, 2026
- 43
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James Edgemond files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
- Christopher Patusky - $2.73M in UTHR purchases and sales in the last 12 months
- Ray Kurzweil - $2.40M in UTHR purchases and sales in the last 12 months
- Tommy G. Thompson - $2.06M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James Edgemond?
James Edgemond is a corporate insider, tracked as CFO AND TREASURER of UNITED THERAPEUTICS Corp (UTHR). InsiderAlpha holds 43 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James Edgemond last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 43 filings going back to 2024.
Has James Edgemond been buying or selling stock?
Recorded transactions: 0 open-market purchases and 405 open-market sales ($226.17M) across all tracked filings.
